Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FERLING
Saint Prex, Vaud, Switzerlandjohnferling.com ↗
- Ownership
- Private
- Employees
- ~7000
- Development stage
- Other
01
Overview
Ferring has multiple commercialized products in reproductive medicine, maternal health, gastroenterology, urology, and the human microbiome. Recent clinical results highlight success in Phase III trials for nadofaragene firadenovec in NMIBC and positive safety/effectiveness data for REBYOTA in recurrent C. diff infection. The company continues to invest heavily in R&D across its core areas.
- Therapeutic areas
- OncologyInfectious DiseasesGastroenterologyWomen's Health
- Modalities
- Small moleculeBiologicMonoclonal antibodyGene therapyMicrobiome-based therapy (Live biotherapeutic product therapy)
- Industry
- Pharma
02
Partnerships
Blackstone Life Sciences (“Fergene” joint venture/gene therapy development)Foresee Pharmaceuticals (“SIF” depot delivery technology collaboration)Celmatix Inc. (“Genomics/big data” collaboration on fertility research)
Beyond the preview
Go deeper on FERLING.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FERLING.